Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jing You

Showing results (421-430 of 425) with videos related to

Pageof 43
Sort By:
You have reached the last page of results.This site can display upto 425 results.
Signal Transduction and Targeted Therapy|March 17, 2023
A new generation M<sup>pro</sup> inhibitor with potent activity against SARS-CoV-2 Omicron variantsChong Huang, Huiping Shuai, Jingxin Qiao, et al.
Science Translational Medicine|February 4, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse modelsHailin Zhang, Yueshan Li, Yin Zhao, et al.
Human Genetics|June 29, 2021
IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel diseaseMara Cananzi, Elizabeth Wohler, Antonio Marzollo, et al.
Environmental Toxicology and Chemistry|June 1, 2020
Toward Sustainable Environmental Quality: Priority Research Questions for AsiaKenneth M Y Leung, Katie W Y Yeung, Jing You, et al.
Science (New York, N.Y.)|February 19, 2021
SARS-CoV-2 M<sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Yue-Shan Li, Rui Zeng, et al.
Pageof 43

Showing results (421-430 of 425) with videos related to

Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 425 results.
Signal Transduction and Targeted Therapy|March 17, 2023
A new generation M<sup>pro</sup> inhibitor with potent activity against SARS-CoV-2 Omicron variantsChong Huang, Huiping Shuai, Jingxin Qiao, et al.
Science Translational Medicine|February 4, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse modelsHailin Zhang, Yueshan Li, Yin Zhao, et al.
Human Genetics|June 29, 2021
IFIH1 loss-of-function variants contribute to very early-onset inflammatory bowel diseaseMara Cananzi, Elizabeth Wohler, Antonio Marzollo, et al.
Environmental Toxicology and Chemistry|June 1, 2020
Toward Sustainable Environmental Quality: Priority Research Questions for AsiaKenneth M Y Leung, Katie W Y Yeung, Jing You, et al.
Science (New York, N.Y.)|February 19, 2021
SARS-CoV-2 M<sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Yue-Shan Li, Rui Zeng, et al.
Pageof 43